Management of recurrent soft tissue sarcoma of the retroperitoneum;Traitement des récidives des sarcomes rétro- péritonéaux

Bulletin du Cancer

Volumn 91, Issue 11, 2004, Pages 845-852

  Bonvalot, Sylvie ^a   Vanel, Daniel ^a   Terrier, Philippe ^a   Robert, Caroline ^a   Le Cesne, Axel ^a   Le Péchoux, Cécile ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Local recurrence; Retroperitoneal surgery

Indexed keywords

IMATINIB;

CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLEARANCE; CLINICAL PROTOCOL; CYTOREDUCTIVE SURGERY; DISEASE COURSE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; METASTASIS; MULTIMODALITY CANCER THERAPY; PREOPERATIVE EVALUATION; PROGNOSIS; RETROPERITONEAL SARCOMA; REVIEW; SOFT TISSUE SARCOMA; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; NEOPLASM RECURRENCE, LOCAL; RETROPERITONEAL NEOPLASMS; SARCOMA;

EID: 11244264978     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Pollock RE, Karnell LH, Mencky HR, Winchester DP. The national data base report on soft tissue sarcoma. Cancer 1996 ; 78 : 2247-57.
2. Mark TM. Sarcoma and other malignancies of soft tissue, retroperitoneum, pleura, mediastinum, and spleen. Cancer 1995 ; 75 : 211-4.
3. Bonvalot S. Retroperitoneal sarcomas: surgical and complementary treatment. J Chir (Paris) 1999 ; 136 : 61-6.
4. Stojadinovic A, Yeh A, Brennan MF. Completely resected recurrent soft tissue sarcoma: primary anatomic site governs outcomes. J Am Coll Surg 2002 ; 194 : 436-47.
5. Eilber FC, Eilber KS, Eilber FR. Retroperitoneal sarcomas. Curr Treat Options Oncol 2000 ; 1 : 274-8.
6. McGrath PC. Retroperitoneal sarcomas. Semin Surg Oncol 1994 ; 10 : 364-8.
7. Demetri GD. Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options. Semin Oncol 2001 ; 28 (suppl. 17) : 19-26.
8. Gupta AK, Cohan RH, Francis IR, Sondak VK, Korobkin M. CT of recurrent retroperitoneal sarcomas. Am J Roentgenol 2000 ; 174 : 1025-30.
9. Hassan I, Park SZ, Donohue JH, Nagorney DM, Kay PA, Nasciemento AG, et al. Operative management of primary retroperitoneal sarcomas: a reappraisal of an institutional experience. Ann Surg 2004 ; 239 : 244-50.
10. Alvarenga JC, Ball AB, Fisher C, Fryatt I, Jones L, Thomas JM. Limitations of surgery in the treatment of retroperitoneal sarcoma. Br J Surg 1991 ; 78 : 912-6.
11. Stoeckle E, Coindre JM, Bonvalot S, Kantor G, Terrier P, Bonichon F, et al., French Federation of Cancer Centers Sarcoma Group. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer 2001 ; 15 : 359-68.
12. Jaques DP, Coit DG, Hajdu SI, Brennan MF. Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum. Ann Surg 1990 ; 212 : 51-9.
13. Van Doom RC, Gallee MP, Hart AA, Gortzak E, Rutgers EJ, Van Coevorden F, et al. Resectable retroperitoneal soft tissue sarcomas. The effect of extent of resection and postoperative radiation therapy on local tumor control. Cancer 1994 ; 73 : 637-42.
14. Karakousis CP, Konrzoglou K, Driscoll DL. Resectability of retroperitoneal sarcomas: a matter of surgical technique? Eur J Surg Oncol 1995 ; 21 : 617-22.
15. Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg 1998 ; 228 : 355-65.
16. Heslin MJ, Lewis JJ, Nadler E, Newman E, Woodruff JM, Casper ES, et al. Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. J Clin Oncol 1997 ; 15 : 2832-9.
17. Singer S, Antonescu CR, Riedel E, Brennan MF. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg 2003 ; 238 : 358-70.
18. Storm FK, Mahvi DM. Diagnosis and management of retroperitoneal soft-tissue sarcoma. Ann Surg 1991 ; 214 : 2-10.
19. Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996 ; 14 : 1679-89.
20. Tanabe KK, Pollock RE, Ellis LM, Murphy A, Sherman N, Romsdahl MM. Influence of surgical margins on outcome in patients with preoperatively irradiated extremity soft tissue sarcomas. Cancer 1994 ; 73 : 1652-9.
21. Goodlad JR, Fletcher CD, Smith MA. Sutgical resection of primary soft-tissue sarcoma. Incidence of residual tumour in 95 patients needing reexcision after local resection. J Bone Joint Surg Br 1996 ; 78 : 658-61.
22. Youssef E, Fontanesi J, Mott M, Kraut M, Lucas D, Mekhael H, BenJosef E. Long-term outcome of combined modality therapy in retroperitoneal and deep-trunk soft-tissue sarcoma: analysis of prognostic factors. Int J Radiat Oncol Biol Phys 2002 ; 54 : 514-9.
23. Singer S, Corson JM, Demetri GD, Healey EA, Marcus K, Eberlein TJ. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg 1995 ; 221 : 185-95.
24. McKee MD, Liu DF, Brooks JJ, Gibbs JF, Driscoll DL, Kraybill WG. The prognostic significance of margin width for extremity and trunk sarcoma. J Surg Oncol 2004 ; 85 : 68-76.
25. Russo P, Kim Y, Ravindran S, Huang W, Brennan MF. Nephrectomy during operarive management of retroperitoneal sarcoma. Ann Surg Oncol 1997 ; 4 : 421-4.
26. Tsivian A, Lev-Chelouche D, Shtabsky A, Issakov J, Sidi AA, Gutman M, et al. Aggressive tesection of tetroperitoneal sarcoma is superior to simple excision: an animal study using a novel model for retroperitoneal sarcoma. Surg Oncol 2002 ; 81 : 144-7.
27. Ng EH, Pollock RE, Munsell MF, Atkinson EN, Romsdahl MM. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging. Ann Surg 1992 ; 215 : 68-77.
28. Van Dalen T, Hoekstra HJ, Van Geel AN, Van Coevorden F, Albus-Lutter C, Slootweg PJ, et al., Dutch Sofr Tissue Sarcoma Group. Locotegional recurrence of retroperitoneal soft tissue sarcoma: second chance of cure for selected patients. Eur J Surg Oncol 2001 ; 27 : 564-8.
29. Van Dalen T, Hennipman A, Van Coevorden F, Hoekstra HJ, Van Geel BN, Slootweg P, et al. Evaluarion of a clinically applicable post-surgical classification system for primary retroperitoneal soft-tissue sarcoma. Ann Surg Oncol 2004 ; 11 : 483-90.
30. Gusrafson P, Dreinhofer KE, Rydholm A. Soft tissue sarcoma should be treated at a tumor center. A comparison of quality of surgery in 375 patients. Acta Orthop Scand 1994 ; 65 : 47-50.
31. Yang JC, ChangAE, Baker AR, Sindelar WF, Danforth DN, Topalian SL, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 1998 ; 16 : 197-203.
32. Carron CN, O'Sullivan B, Kotwall C, Cummings B, Hao Y, Fornasier V. Outcome and prognosis in retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys 1994 ; 29 : 1005-10.
33. Sindelar WF, Kinsella TJ, Chen PW, DeLaney TF, Tepper JE, Rosenberg SA, et al. Intraoperative radiotherapy in rerroperitoneal sarcomas. Final results of a prospective, randomized, clinical trial. Arch Surg 1993 ; 128 : 402-10.
34. Glenn J, Sindelar WF, Kinsella T, Glatstein E, Tepper J, Costa J, et al. Results of multimodality therapy of resectable soft-tissue sarcomas of the retroperitoneum. Surgery 1985 ; 97 : 316-25.
35. Gieschen HL, Spiro IJ, Suit HD, Ott MJ, Rattner DW, Ancukiewicz M, et al. Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys 2001 ; 50 : 127-31.
36. Jones JJ, Catton CN, O'Sullivan B, Couture J, Heisler RL, Kandel RA, et al. Initial results of a trial of preoperative external-beam radiation therapy and postoperative brachytherapy for retroperironeal sarcoma. Ann Surg Oncol 2002 ; 9 : 346-54.
37. Petersen IA, Haddock MG, Donohue JH, Nagorney DM, Grill JP, Sargent DJ, et al. Use of intraoperative electron beam radiotherapy in the management of retroperitoneal soft tissue sarcomas. Int J Radiat Oncol Biol Phys 2002 ; 52 : 469-75.
38. Bautista N, Su W, O'Connell TX. Retroperitoneal soft-tissue sarcomas: prognosis and treatment of primary and recurrent disease. Am Surg 2000 ; 66 : 832-6.
39. Shibata D, Lewis JJ, Leung DH, Brennan MF. Is there a role for incomplete resection in the management of retroperitoneal liposarcomas? Am Coll Surg 2001 ; 193 : 373-9.
40. Alektiar KM, Hu K, Anderson L, Brennan MF, Harrison LB. High-dose-rate intraoperative radiation therapy (HDR-IORT) for retroperitoneal sarcomas. Int J Radiat Oncol Biol Phys 2000 ; 47 : 157-63.
41. Gilbeau L, Kantor G, Stoeckle E, Lagarde P, Thomas L, Kind M, et al. Surgical resection and radiotherapy for primary retroperitoneal soft tissue sarcoma. Radiother Oncol 2002 ; 65 : 137-43.
42. Bussieres E, Stockle EP, Richaud PM, Avril AR, Kind MM, Kantor G, et al. Retroperitoneal soft tissue sarcomas: a pilot study of intraoperative radiation therapy. J Surg Oncol 1996 ; 62 : 49-56.
43. Rossi CR, Deraco M, De Simone M, Mocellin S, Pilati P, Foletto M, et al. Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatmenr of abdominal sarcomatosis: clinical outcome and prognostic factors in 60 consecutive patients. Cancer 2004 ; 100 : 1943-50.
44. Bonvalot S, Cavalcanti A, Le Péchoux C, Vanel D, Blay JY, Le Cesne A, Elias D. Randomized trial of cytoreduction followed by intraperitoneal chemotherapy versus cytoreduction alone in patients with peritoneal sarcomatosis. 2004 ; Soumis à publication.
45. Van Geel AN, Pastorino U, Jauch KW, Judson IR, Van Coevorden F, Buesa JM, et al. Surgical treatment of lung metastases: The European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study of 255 patients. Cancer 1996 ; 77 : 675-82.
46. Choong PF, Pritchard DJ, Rock MG, Sim FH, Frassica FJ. Survival after pulmonary metastasectomy in soft tissue sarcoma. Prognostic factors in 214 patients. Acta Orthop Scand 1995 ; 66 : 561-8.
47. Billingsley KG, Burr ME, Jara E, Ginsberg RJ, Woodruff JM, Leung DH, et al. Pulmonary metastases from soft tissue satcoma: analysis of patterns of diseases and postmetastasis survival. Ann Surg 1999 ; 229 : 602-10.
48. DeMarteo RP, Shah A, Fong Y, Jarnagin WR, Blumgart LH, Brennan MF. Results of hepatic resection for sarcoma metastatic to liver. Ann Surg 2001 ; 234 : 540-7.
49. Silberman S, Joensuu H. Overview of issues related to imatinib therapy of advanced gastrointestinal stromal tumors: a discussion among the experts. Eur J Cancer 2002 ; 38 (suppl. 5) : S66-9.
50. Gomez Abuin G, Lassalle M, Bonvalot S, Terrier P, Le Péchoux C, Vanel D, et al. Intensive induction chemotherapy (API AI regimen) followed by conservative surgery in patients with locally advanced soft tissue sarcoma: survival is predicted by the histological response. Proc Am Soc Clin Oncol 2004 : 9036 ; (abstract).
51. Wang YN, Zhu WQ, Shen ZZ, Li S, Liu SY. Treatment of locally recurrent soft tissue sarcomas of the retroperitoneum: report of 30 cases. J Surg Oncol 1994 ; 56 : 213-6.
52. Le Cesne A. Chimiothérapie des sarcomes des tissus mous métastatiques. Presse Med 1995 ; 24 : 1214-20.
53. Debled M, Revaud A, Stoeckle E, Nguyen BB. Role of adjuvant chemotherapy in the treatmenr of soft rissue sarcoma. Bull Cancer 1997 ; 84 : 653-63.